<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1993-04-01" modified="2020-06-17" version="64">
<accession>P29827</accession>
<name>CINA_STRGV</name>
<protein>
<recommendedName>
<fullName>Lantibiotic cinnamycin</fullName>
</recommendedName>
<alternativeName>
<fullName>Lanthiopeptin</fullName>
</alternativeName>
<alternativeName>
<fullName>Lantibiotic Ro 09-0198</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">cinA</name>
<name type="synonym">rocA</name>
</gene>
<organism>
<name type="scientific">Streptomyces griseoverticillatus</name>
<name type="synonym">Streptoverticillium griseoverticillatum</name>
<dbReference type="NCBI Taxonomy" id="68215"/>
<lineage>
<taxon>Bacteria</taxon>
<taxon>Actinobacteria</taxon>
<taxon>Streptomycetales</taxon>
<taxon>Streptomycetaceae</taxon>
<taxon>Streptomyces</taxon>
<taxon>Streptomyces cinnamoneus group</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="Eur. J. Biochem." volume="199" first="411" last="415">
<title>Prepeptide sequence of cinnamycin (Ro 09-0198): the first structural gene of a duramycin-type lantibiotic.</title>
<authorList>
<person name="Kaletta C."/>
<person name="Entian K.-D."/>
<person name="Jung G."/>
</authorList>
<dbReference type="PubMed" id="2070795"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1991.tb16138.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<strain>MAR 164C-MY6</strain>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1990" name="J. Antibiot." volume="43" first="1403" last="1412">
<title>Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin.</title>
<authorList>
<person name="Fredenhagen A."/>
<person name="Fendrich G."/>
<person name="Marki F."/>
<person name="Marki W."/>
<person name="Gruner J."/>
<person name="Raschdorf F."/>
<person name="Peter H.H."/>
</authorList>
<dbReference type="PubMed" id="2125590"/>
<dbReference type="DOI" id="10.7164/antibiotics.43.1403"/>
</citation>
<scope>PROTEIN SEQUENCE OF 60-78</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1989" name="J. Antibiot." volume="42" first="837" last="845">
<title>Lanthiopeptin, a new peptide antibiotic. Production, isolation and properties of lanthiopeptin.</title>
<authorList>
<person name="Naruse N."/>
<person name="Tenmyo O."/>
<person name="Tomita K."/>
<person name="Konishi M."/>
<person name="Miyaki T."/>
<person name="Kawaguchi H."/>
<person name="Fukase K."/>
<person name="Wakamiya T."/>
<person name="Shiba T."/>
</authorList>
<dbReference type="PubMed" id="2544544"/>
<dbReference type="DOI" id="10.7164/antibiotics.42.837"/>
</citation>
<scope>PROTEIN SEQUENCE OF 60-78</scope>
<scope>HYDROXYLATION AT ASP-74</scope>
</reference>
<comment type="function">
<text>Can act as inhibitor of the enzyme phospholipase A2, and of the angiotensin-converting enzyme. Shows inhibitory activities against herpes simplex virus and immunopotentiating activities. Its antimicrobial activities are not very pronounced.</text>
</comment>
<comment type="PTM">
<text>Maturation of lantibiotics involves the enzymatic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine or the formation of dialkylamine bonds with lysine. This is followed by membrane translocation and cleavage of the modified precursor.</text>
</comment>
<comment type="similarity">
<text evidence="4">Belongs to the type B lantibiotic family.</text>
</comment>
<dbReference type="EMBL" id="X58545">
<property type="protein sequence ID" value="CAA41436.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="PIR" id="A45767">
<property type="entry name" value="EWSMCN"/>
</dbReference>
<dbReference type="PIR" id="S17181">
<property type="entry name" value="EWSMYG"/>
</dbReference>
<dbReference type="PDB" id="2DDE">
<property type="method" value="NMR"/>
<property type="chains" value="A=60-78"/>
</dbReference>
<dbReference type="PDBsum" id="2DDE"/>
<dbReference type="SMR" id="P29827"/>
<dbReference type="DrugBank" id="DB04731">
<property type="generic name" value="1-ACETYL-2-LYSO-SN-GLYCERO-3-PHOSPHOETHANOLAMINE"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:signaling receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0019835">
<property type="term" value="P:cytolysis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042742">
<property type="term" value="P:defense response to bacterium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0044">Antibiotic</keyword>
<keyword id="KW-0929">Antimicrobial</keyword>
<keyword id="KW-0078">Bacteriocin</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0379">Hydroxylation</keyword>
<keyword id="KW-0425">Lantibiotic</keyword>
<keyword id="KW-0883">Thioether bond</keyword>
<feature type="propeptide" id="PRO_0000017148" evidence="2">
<location>
<begin position="1"/>
<end position="59"/>
</location>
</feature>
<feature type="peptide" description="Lantibiotic cinnamycin" id="PRO_0000017149">
<location>
<begin position="60"/>
<end position="78"/>
</location>
</feature>
<feature type="modified residue" description="(3R)-3-hydroxyaspartate" evidence="3">
<location>
<position position="74"/>
</location>
</feature>
<feature type="cross-link" description="Beta-methyllanthionine (Cys-Thr)">
<location>
<begin position="60"/>
<end position="77"/>
</location>
</feature>
<feature type="cross-link" description="Lanthionine (Ser-Cys)">
<location>
<begin position="63"/>
<end position="73"/>
</location>
</feature>
<feature type="cross-link" description="Beta-methyllanthionine (Cys-Thr)">
<location>
<begin position="64"/>
<end position="70"/>
</location>
</feature>
<feature type="cross-link" description="Lysinoalanine (Ser-Lys)">
<location>
<begin position="65"/>
<end position="78"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="65"/>
<end position="72"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2DDE"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000255"/>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2544544"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000305"/>
<sequence length="78" mass="8205" checksum="0ACDAE6BA54E5E7A" modified="1993-04-01" version="1" precursor="true">MTASILQQSVVDADFRAALLENPAAFGASAAALPTPVEAQDQASLDFWTKDIAATEAFACRQSCSFGPFTFVCDGNTK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>
